Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C12orf10 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | CTBP1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | KCNH4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RAB6A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | VSX2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | NPIPB7 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | SCRT2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | FGF22 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |